Trial Profile

A global phase 2/3 trial of Vactosertib in for the colorectal cancer patients

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 05 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

18 Jun 2024 Status changed from planning to recruiting, according to a MedPacto media release.
18 Jun 2024 According to a MedPacto media release, It received approval for a phase 2b/3 clinical trial from the FDA in January and is currently conducting a clinical trial combining vactosertib and Keytruda.
07 Dec 2023 According to a MedPacto media release, trial will begin in earnest with the first patient administration in the second half of next year.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com